Ultra-low-dose estradiol and dydrogesterone: a phase III study for vasomotor symptoms in China.

This study aimed to evaluate the efficacy and safety of ultra-low-dose estradiol plus dydrogesterone for vasomotor symptoms in postmenopausal women in China (trial registration CTR20160689).A total...